Citadel Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Sell
241,755
-1,091,337
-82% -$78.7M ﹤0.01% 2421
2025
Q4
$85.1M Buy
1,333,092
+275,096
+26% +$17M 0.01% 962
2025
Q3
$66.7M Buy
1,057,996
+582,946
+123% +$40.7M 0.01% 1125
2025
Q2
$35.5M Buy
475,050
+387,724
+444% +$30.5M 0.01% 1525
2025
Q1
$7.69M Sell
87,326
-964,071
-92% -$91M ﹤0.01% 3222
2024
Q4
$96M Buy
1,051,397
+387,513
+58% +$39.7M 0.02% 753
2024
Q3
$74.3M Sell
663,884
-72,027
-10% -$7.2M 0.01% 915
2024
Q2
$72.1M Sell
735,911
-142,025
-16% -$14.1M 0.01% 869
2024
Q1
$88M Sell
877,936
-437,029
-33% -$38.4M 0.02% 790
2023
Q4
$118M Buy
1,314,965
+1,310,993
+33,006% +$104M 0.02% 595
2023
Q3
$305K Sell
3,972
-107,977
-96% -$8.96M ﹤0.01% 9141
2023
Q2
$9.37M Buy
111,949
+99,070
+769% +$8.06M ﹤0.01% 2767
2023
Q1
$1.09M Buy
12,879
+4,936
+62% +$424K ﹤0.01% 6589
2022
Q4
$647K Sell
7,943
-179,748
-96% -$14.5M ﹤0.01% 7711
2022
Q3
$13.3M Buy
187,691
+52,312
+39% +$4.7M ﹤0.01% 2368
2022
Q2
$12.2M Sell
135,379
-73,174
-35% -$7.57M ﹤0.01% 2428
2022
Q1
$23.4M Buy
208,553
+138,241
+197% +$16.2M ﹤0.01% 1807
2021
Q4
$8.5M Sell
70,312
-215,801
-75% -$24M ﹤0.01% 3342
2021
Q3
$28.8M Sell
286,113
-198
-0.1% -$21.8K 0.01% 1601
2021
Q2
$33.4M Buy
286,311
+261,265
+1,043% +$31.4M 0.01% 1504
2021
Q1
$2.76M Sell
25,046
-6,000
-19% -$652K ﹤0.01% 5639
2020
Q4
$3.11M Buy
+31,046
New +$2.88M ﹤0.01% 4531
2020
Q2
Sell
-292,626
Closed -$18.4M 9938
2020
Q1
$13.6M Buy
292,626
+193,066
+194% +$12.4M 0.01% 1556
2019
Q4
$7.89M Buy
99,560
+42,250
+74% +$3.25M ﹤0.01% 2487
2019
Q3
$4.23M Sell
57,310
-90,558
-61% -$6.5M ﹤0.01% 3336
2019
Q2
$11.5M Sell
147,868
-1,215,345
-89% -$92.3M 0.01% 2014
2019
Q1
$103M Buy
1,363,213
+818,279
+150% +$65M 0.05% 350
2018
Q4
$39.8M Buy
544,934
+541,155
+14,320% +$43.1M 0.02% 746
2018
Q3
$362K Sell
3,779
-113,956
-97% -$11.3M ﹤0.01% 7264
2018
Q2
$11.8M Buy
117,735
+109,394
+1,312% +$11.5M 0.01% 1777
2018
Q1
$881K Sell
8,341
-37,666
-82% -$3.81M ﹤0.01% 5014
2017
Q4
$4.26M Buy
46,007
+10,397
+29% +$945K ﹤0.01% 2669
2017
Q3
$3.22M Sell
35,610
-1,057,063
-97% -$90M ﹤0.01% 2821
2017
Q2
$91.8M Buy
1,092,673
+631,320
+137% +$50.9M 0.08% 255
2017
Q1
$37.3M Buy
461,353
+233,658
+103% +$18.4M 0.03% 593
2016
Q4
$17.1M Sell
227,695
-842,568
-79% -$60.8M 0.02% 968
2016
Q3
$72.4M Buy
1,070,263
+1,036,798
+3,098% +$69.6M 0.07% 243
2016
Q2
$2.27M Buy
33,465
+12,444
+59% +$915K ﹤0.01% 2610
2016
Q1
$1.52M Sell
21,021
-35,124
-63% -$2.3M ﹤0.01% 2972
2015
Q4
$3.79M Sell
56,145
-719,040
-93% -$50.3M ﹤0.01% 2074
2015
Q3
$50.2M Sell
775,185
-538,256
-41% -$39.7M 0.05% 434
2015
Q2
$107M Sell
1,313,441
-650,174
-33% -$50.1M 0.09% 215
2015
Q1
$136M Buy
1,963,615
+1,324,297
+207% +$95.6M 0.13% 148
2014
Q4
$48.5M Sell
639,318
-354,285
-36% -$28M 0.05% 487
2014
Q3
$80.4M Buy
993,603
+939,254
+1,728% +$78.4M 0.08% 235
2014
Q2
$4.75M Sell
54,349
-770,801
-93% -$67M 0.01% 1874
2014
Q1
$71.1M Sell
825,150
-309,236
-27% -$25.3M 0.08% 257
2013
Q4
$91.5M Buy
1,134,386
+994,267
+710% +$77.2M 0.12% 172
2013
Q3
$10.9M Buy
140,119
+23,007
+20% +$1.77M 0.02% 1046
2013
Q2
$8.2M Buy
+117,112
New +$8.16M 0.01% 1199

Other funds holding EMN

Citadel Advisors's EMN Position: Q1 2026 in Review

Citadel Advisors reduced its Eastman Chemical (EMN) stake by 82% in Q1 2026, selling an estimated $78.7M and leaving 241,755 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Citadel Advisors first reported a position in EMN in Q2 2013 and has held it in 50 quarters since. The position peaked at $136M in Q1 2015. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Citadel Advisors held 241,755 shares of Eastman Chemical worth $18.5M as of Q1 2026.
  • Citadel Advisors sold 1,091,337 Eastman Chemical shares in Q1 2026, an estimated $78.7M.
  • Eastman Chemical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2421 holding.
  • Citadel Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Eastman Chemical position peaked at $136M in Q1 2015.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.